Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Cancer Letters|February 5, 2013
Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?Markus D Siegelin
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 2014
Epidermal growth factor receptor mutations in lung adenocarcinomaMarkus D Siegelin, Alain C Borczuk
Cells|May 13, 2025
Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell CytotoxicityQing Zhou, Markus D Siegelin, Lloyd A Greene
Cancer Research|October 28, 2010
Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cellsJagadish C Ghosh, Markus D Siegelin, Takehiko Dohi, et al.
Cells|February 25, 2023
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other CancersLloyd A Greene, Qing Zhou, Markus D Siegelin, et al.
Neurochemistry International|May 12, 2009
p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomasTimo Gaiser, Maria R Becker, Jochen Meyer, et al.
Oncoscience|April 8, 2020
Metabolic Reprogramming by c-MET Inhibition as a Targetable Vulnerability in GlioblastomaTrang Thi Thu Nguyen, Enyuan Shang, Georg Karpel-Massler, et al.
CNS Drugs|November 27, 2019
Novel IDH1-Targeted Glioma TherapiesGeorg Karpel-Massler, Trang T T Nguyen, Enyuan Shang, et al.
Melanoma Research|May 12, 2009
COX-2 expression in malignant melanoma: a novel prognostic marker?Maria R Becker, Markus D Siegelin, Rainer Rompel, et al.
Neuro-Oncology|October 31, 2008
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cellsMarkus D Siegelin, David E Reuss, Antje Habel, et al.
Pageof 9